|
Recent Developments |
|
30-MAY-13
Medicamen Biotech announced that its board of directors appointed Jitendra Nath Ojha as additional director & further appointed him as whole-time director w.e.f. May 30, 2013.
12-DEC-11
Medicamen Biotech has announced that the Company gets Anvisa Brazil approval for Non Beta Lactum solid tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi, Rajasthan vide Resolution 5397 No RE of Dec. 02, 2... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 777.94 | 732.49 | 639.98 | | Other Income | 11.00 | 6.06 | 7.32 | | Total Income | 788.94 | 738.55 | 647.30 | | Cost of goods sold | 738.63 | 691.71 | 654.24 | | OPBDIT | 50.31 | 46.84 | -6.94 | | PAT | 4.41 | 0.94 | -49.28 | | Gross Block | - | - | - | | Equity capital | 95.11 | 89.14 | 84.90 | | EPS (Rs.) | 0.49 | 0.11 | -5.88 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | 15.51 - 39.29 | 43.18 - 109.00 | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 6.4 | 6.3 | -1.1 | | Net margin (% of OI) | 0.6 | 0.1 | -7.6 |
|
|
Detailed Financials
|
|
|
|
|
